
If any worried faces were detected this morning among the around 700 people working at the implant division of hearing aid manufacturer Demant, it is well understood why.
Wednesday morning, the parent company announced that Australian firm Cochlear is set to take over the business dealing with both bone-anchored solutions and cochlear implants for DKK 850m (USD 121.5m).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app